ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 221 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2013. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,308,000 | -19.9% | 180,900 | -35.9% | 0.08% | -22.2% |
| Q4 2016 | $2,880,000 | +1258.5% | 282,100 | +1652.2% | 0.10% | +2375.0% |
| Q3 2016 | $212,000 | -83.0% | 16,100 | -83.6% | 0.00% | -90.5% |
| Q2 2016 | $1,247,000 | -76.0% | 98,200 | -75.0% | 0.04% | -72.5% |
| Q1 2016 | $5,198,000 | -6.8% | 393,500 | +8.5% | 0.15% | +10.1% |
| Q4 2015 | $5,578,000 | +4001.5% | 362,700 | +3197.3% | 0.14% | +2680.0% |
| Q3 2015 | $136,000 | -96.7% | 11,000 | -96.3% | 0.01% | -95.2% |
| Q2 2015 | $4,093,000 | +13.6% | 299,200 | -0.7% | 0.10% | +5.0% |
| Q1 2015 | $3,604,000 | +2335.1% | 301,300 | +2497.4% | 0.10% | +1900.0% |
| Q4 2014 | $148,000 | -91.2% | 11,600 | -90.7% | 0.01% | -92.1% |
| Q3 2014 | $1,677,000 | -30.7% | 125,000 | -17.1% | 0.06% | -42.7% |
| Q2 2014 | $2,419,000 | +66.0% | 150,700 | +53.8% | 0.11% | -16.7% |
| Q3 2013 | $1,457,000 | +654.9% | 98,000 | +557.7% | 0.13% | +560.0% |
| Q2 2013 | $193,000 | – | 14,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |